Literature DB >> 1970554

Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.

W D Zhang1, S Hirohashi, H Tsuda, Y Shimosato, J Yokota, M Terada, T Sugimura.   

Abstract

By restriction fragment length polymorphism analysis, we examined loss of heterozygosity at 34 loci on 23 chromosomes in 35 surgically resected human hepatocellular carcinomas. Allele losses at the HP locus on chromosome 16q22 and at the MT2P1 locus on chromosome 4p11-q21 were detected in 57% (8/14) and 50% (8/16) of cases, respectively. Loss of heterozygosity on chromosomes 16q and 4 occurred simultaneously in 4 of 7 informative cases for both loci, and seemed to be important in the development of human hepatocellular carcinoma irrespective of the presence of hepatitis B virus infection. In contrast, the incidence of allele loss was low at the other loci, e.g., chromosome 1p, 3p, 11p, 13q or 17p, where one allele is frequently lost in other cancers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970554      PMCID: PMC5963891          DOI: 10.1111/j.1349-7006.1990.tb02534.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


hepatocellular carcinoma restriction fragment length polymorphism hepatitis B virus sodium dodecyl sulfate hepatitis B surface antigen
  28 in total

1.  Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  K Ashida; Y Kishimoto; K Nakamoto; K Wada; G Shiota; Y Hirooka; Y Kamisaki; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.

Authors:  Kate Revill; Tim Wang; Anja Lachenmayer; Kensuke Kojima; Andrew Harrington; Jinyu Li; Yujin Hoshida; Josep M Llovet; Scott Powers
Journal:  Gastroenterology       Date:  2013-09-05       Impact factor: 22.682

3.  Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  Y Kishimoto; G Shiota; K Wada; M Kitano; K Nakamoto; Y Kamisaki; T Suou; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 4.  Alteration of WWOX in human cancer: a clinical view.

Authors:  Izabela Baryła; Ewa Styczeń-Binkowska; Andrzej K Bednarek
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-13

Review 5.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

6.  Expression of cytoskeletal-associated protein tyrosine phosphatase PTPH1 mRNA in human hepatocellular carcinoma.

Authors:  S Ikuta; F Itoh; Y Hinoda; M Toyota; Y Makiguchi; K Imai; A Yachi
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

7.  Identification of hepatocarcinogen-resistance genes in DBA/2 mice.

Authors:  G H Lee; L M Bennett; R A Carabeo; N R Drinkwater
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

8.  Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.

Authors:  M Saegusa; Y Takano; H Kishimoto; G Wakabayashi; K Nohga; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 9.  Hepatocarcinogenesis in rodents and humans.

Authors:  T Kitagawa; K Miyasaka; H Kanda; H Yasui; O Hino
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 10.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.